Cargando…

Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patients

INTRODUCTION: The antiviral drug favipiravir has been shown to have in vitro antiviral activity against severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2). In this study, we investigated the clinical benefits and initiation of favipiravir treatment in patients with non-severe coronavirus-d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujii, Satoshi, Ibe, Yuta, Ishigo, Tomoyuki, Inamura, Hirotoshi, Kunimoto, Yusuke, Fujiya, Yoshihiro, Kuronuma, Koji, Nakata, Hiromasa, Fukudo, Masahide, Takahashi, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052467/ https://www.ncbi.nlm.nih.gov/pubmed/33902990 http://dx.doi.org/10.1016/j.jiac.2021.04.013

Ejemplares similares

Delayed dexamethasone treatment at initiation of oxygen supplementation for coronavirus disease 2019 is associated with the exacerbation of clinical condition
por: Ibe, Yuta, et al.
Publicado: (2022)

Tazobactam/ceftolozane and tobramycin combination therapy in extensively drug-resistant Pseudomonas aeruginosa infections in severe burn injury: a case report
por: Ibe, Yuta, et al.
Publicado: (2023)

Simulation of Vancomycin Exposure Using Trough and Peak Levels Achieves the Target Area under the Steady-State Concentration–Time Curve in ICU Patients
por: Ibe, Yuta, et al.
Publicado: (2023)

Early Defervescence and SARS Recovery
por: Wang, Jann-Tay, et al.
Publicado: (2004)

Potential drug–drug interactions in the era of integrase strand transfer inhibitors: a cross-sectional single-center study in Japan
por: Kunimoto, Yusuke, et al.
Publicado: (2021)

Lecture on the Course of the Temperature in Defervescence
por: Finlayson, James
Publicado: (1875)

Acute eosinophilic pneumonia accompanied with COVID‐19: a case report
por: Murao, Koutaro, et al.
Publicado: (2020)

Drug interactions between ALK inhibitors and warfarin with concurrent use of bucolome: a case report
por: Kato, Takashi, et al.
Publicado: (2023)

Utility of a Score for Predicting Glomerular Filtration Rate Overestimation in Patients with Cardiovascular and Renal Diseases and Their Risk Factors
por: Ishigo, Tomoyuki, et al.
Publicado: (2022)

Factors affecting the sensitivity of quantitative severe acute respiratory syndrome coronavirus 2 antigen test
por: Sato, Yuki, et al.
Publicado: (2023)

Beneficial effects of early empirical administration of appropriate antimicrobials on survival and defervescence in adults with community-onset bacteremia
por: Lee, Ching-Chi, et al.
Publicado: (2019)

Invasive pneumococcal disease affected the fatal outcome in a COVID-19 patient
por: Kuronuma, Koji, et al.
Publicado: (2021)

Spontaneous defervescence and its prediction in the acute phase of Kawasaki disease
por: Shin, Eun Jung, et al.
Publicado: (2022)

Outcomes of Kawasaki Disease Children With Spontaneous Defervescence Within 10 Days
por: Hu, Ya-Chiao, et al.
Publicado: (2019)

Management of aplastic anemia during the phase of defervescence of the COVID-19 pandemic()
por: Vallejo Llamas, Juan Carlos
Publicado: (2021)

Plasma tenofovir trough concentrations are associated with renal dysfunction in Japanese patients with HIV infection: a retrospective cohort study
por: Kunimoto, Yusuke, et al.
Publicado: (2016)

Analysis of diagnostic performance and factors causing nonspecific reactions in SARS-CoV-2 rapid antigen detection tests
por: Narumi, Natsuki, et al.
Publicado: (2023)

Defervescent dengue patients might be a potential source of infection for vector mosquitoes
por: Xu, Ye, et al.
Publicado: (2020)

Does the timing of saliva collection affect the diagnosis of SARS-CoV-2 infection?
por: Katayama, Yuki, et al.
Publicado: (2022)

Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection
por: Fujiya, Yoshihiro, et al.
Publicado: (2022)

Development of coronary artery lesions in indolent kawasaki disease following initial spontaneous defervescence: a retrospective cohort study
por: Takahashi, Takuto, et al.
Publicado: (2015)

Favipiravir and the Need for Early Ambulatory Treatment of COVID-19
por: Korman, Tony M.
Publicado: (2021)

Effectiveness of Early Favipiravir Therapy in Hospitalised COVID-19 Patients
por: Tawfik, Abdulrahman, et al.
Publicado: (2022)

Population pharmacokinetics of favipiravir in patients with COVID‐19
por: Irie, Kei, et al.
Publicado: (2021)

Impaired tryptophan metabolism in the gastrointestinal tract of patients with critical coronavirus disease 2019
por: Yokoyama, Yoshihiro, et al.
Publicado: (2022)

Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19
por: Irie, Kei, et al.
Publicado: (2020)

Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial
por: McMahon, James H., et al.
Publicado: (2022)

Single-cell temporal analysis of natural dengue infection reveals skin-homing lymphocyte expansion one day before defervescence
por: Arora, Jantarika Kumar, et al.
Publicado: (2022)

Pseudo-outbreak of Mycobacterium lentiflavum at a general hospital in Japan
por: Nagano, Yutaro, et al.
Publicado: (2023)

Primary and Secondary Syphilis as Chancre of the Mouth with Rash
por: Kutsuna, Satoshi, et al.
Publicado: (2017)

Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases
por: Murohashi, Kota, et al.
Publicado: (2020)

Association of Early Favipiravir Use with Reduced COVID-19 Fatality among Hospitalized Patients
por: Karatas, Ercan, et al.
Publicado: (2021)

CT Coronary Angiography Studies After a Mean Follow-up of 3.8 Years in Children With Kawasaki Disease and Spontaneous Defervescence
por: Dusad, Santosh, et al.
Publicado: (2020)

Pneumocystis jirovecii Pneumonia Associated with COVID-19 in Patients with Interstitial Pneumonia
por: Takahashi, Tomoyuki, et al.
Publicado: (2022)

Evaluating a novel, highly sensitive, and quantitative reagent for detecting SARS-CoV-2 antigen
por: Kobayashi, Ryo, et al.
Publicado: (2021)

Factors associated with afebrile presentation and delayed defervescence of bacterial meningitis in children under 3 years of age: a multi-centre retrospective analysis
por: He, Lin, et al.
Publicado: (2023)

Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV-2 Infection (COVID-19)
por: McCullough, Peter A.
Publicado: (2020)

ICU admission and favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19
por: Doi, Yohei, et al.
Publicado: (2020)

COVID‐19 pneumonia suspected to be co‐infection with Mycoplasma pneumoniae and improved by early administration of favipiravir and ciclesonide
por: Ito, Keima, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0skvleag5csfmt6rb88m12jsue